Magenta Therapeutics, Inc.·4

Jun 18, 5:18 PM ET

COOKE MICHAEL P. 4

4 · Magenta Therapeutics, Inc. · Filed Jun 18, 2019

Insider Transaction Report

Form 4
Period: 2019-06-17
COOKE MICHAEL P.
Chief Scientific Officer
Transactions
  • Sale

    common stock

    2019-06-17$13.90/sh7,500$104,267285,523 total
Footnotes (2)
  • [F1]This trade is pursuant to an active 10b5-1 plan.
  • [F2]This transaction was executed in multiple trades at prices ranging from $13.72 to $14.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT